362 related articles for article (PubMed ID: 12182539)
21. Brown spiders and loxoscelism.
da Silva PH; da Silveira RB; Appel MH; Mangili OC; Gremski W; Veiga SS
Toxicon; 2004 Dec; 44(7):693-709. PubMed ID: 15500846
[TBL] [Abstract][Full Text] [Related]
22. Astacin-like metalloproteases are a gene family of toxins present in the venom of different species of the brown spider (genus Loxosceles).
Trevisan-Silva D; Gremski LH; Chaim OM; da Silveira RB; Meissner GO; Mangili OC; Barbaro KC; Gremski W; Veiga SS; Senff-Ribeiro A
Biochimie; 2010 Jan; 92(1):21-32. PubMed ID: 19879318
[TBL] [Abstract][Full Text] [Related]
23. [Obtention of an antivenom against Phoneutria nigriventer (arachnida; ctenidae) venom].
de Roodt AR; Gutiérrez LR; Rufino Caro R; Lago NR; Montenegro JL
Arch Argent Pediatr; 2011 Feb; 109(1):62-5. PubMed ID: 21283947
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics in rabbits and anti-sphingomyelinase D neutralizing power of Fab, F(ab')(2), IgG and IgG(T) fragments from hyper immune equine plasma.
Vázquez H; Olvera F; Paniagua-Solís J; Alagón A; Sevcik C
Int Immunopharmacol; 2010 Apr; 10(4):447-54. PubMed ID: 20093203
[TBL] [Abstract][Full Text] [Related]
25. Design and Production of a Recombinant Hybrid Toxin to Raise Protective Antibodies Against
Calabria PAL; Shimokava-Falcao LHAL; Colombini M; Moura-da-Silva AM; Barbaro KC; Faquim-Mauro EL; Magalhaes GS
Toxins (Basel); 2019 Feb; 11(2):. PubMed ID: 30759862
[TBL] [Abstract][Full Text] [Related]
26. Molecular cloning, expression, function and immunoreactivities of members of a gene family of sphingomyelinases from Loxosceles venom glands.
Tambourgi DV; de F Fernandes Pedrosa M; van den Berg CW; Gonçalves-de-Andrade RM; Ferracini M; Paixão-Cavalcante D; Morgan BP; Rushmere NK
Mol Immunol; 2004 Jul; 41(8):831-40. PubMed ID: 15234562
[TBL] [Abstract][Full Text] [Related]
27. Inflammatory mediators generated at the site of inoculation of Loxosceles gaucho spider venom.
Barbaro KC; Lira MS; Araújo CA; Pareja-Santos A; Távora BC; Prezotto-Neto JP; Kimura LF; Lima C; Lopes-Ferreira M; Santoro ML
Toxicon; 2010 Nov; 56(6):972-9. PubMed ID: 20615425
[TBL] [Abstract][Full Text] [Related]
28. A prokaryote system optimization for rMEPLox expression: A promising non-toxic antigen for Loxosceles antivenom production.
Saavedra-Langer R; Costa TGF; Lima SA; Costal-Oliveira F; Martins CA; Machado-de-Ávila RA; Minozzo JC; Soccol VT; Guerra-Duarte C; Kalapothakis E; Chávez-Olórtegui C
Int J Biol Macromol; 2021 Sep; 187():66-75. PubMed ID: 34246677
[TBL] [Abstract][Full Text] [Related]
29. Partial in vivo protection against Peruvian spider Loxosceles laeta venom by immunization with a multiepitopic protein (rMEPLox).
Quispe RL; Jaramillo ML; Torres-Huaco F; Bonilla C; Isasi J; Guerra-Duarte C; Chávez-Olórtegui C
Toxicon; 2022 Aug; 215():1-5. PubMed ID: 35660625
[TBL] [Abstract][Full Text] [Related]
30. Development and evaluation of the neutralizing capacity of horse antivenom against the Brazilian spider Loxosceles intermedia.
Braz A; Minozzo J; Abreu JC; Gubert IC; Chávez-Olórtegui C
Toxicon; 1999 Sep; 37(9):1323-8. PubMed ID: 10400292
[TBL] [Abstract][Full Text] [Related]
31. Immunoprotection elicited in rabbit by a chimeric protein containing B-cell epitopes of Sphingomyelinases D from Loxosceles spp. spiders.
Souza NA; Dias-Lopes C; Matoso ÍHG; de Oliveira CFB; Chávez-Olortegui CD; Minozzo JC; Felicori LF
Vaccine; 2018 Nov; 36(48):7324-7330. PubMed ID: 30352745
[TBL] [Abstract][Full Text] [Related]
32. Production of monoclonal antibodies capable of neutralizing dermonecrotic activity of Loxosceles intermedia spider venom and their use in a specific immunometric assay.
Alvarenga LM; Martins MS; Moura JF; Kalapothakis E; Oliveira JC; Mangili OC; Granier C; Chávez-Olórtegui C
Toxicon; 2003 Dec; 42(7):725-31. PubMed ID: 14757202
[TBL] [Abstract][Full Text] [Related]
33. Engineered antigen containing epitopes from Loxosceles spp. spider toxins induces a monoclonal antibody (Lox-mAb3) against astacin-like metalloproteases.
Costa TGF; Costal-Oliveira F; de Assis TCS; Lima SA; Martins CA; Finco AB; Veiga SS; Soccol VT; Machado-de-Ávila RA; Figueiredo LFM; Minozzo JC; Kalapothakis E; Guerra-Duarte C; Alvarenga LM; Chávez-Olórtegui C
Int J Biol Macromol; 2020 Nov; 162():490-500. PubMed ID: 32574737
[TBL] [Abstract][Full Text] [Related]
34. A Web of Coagulotoxicity: Failure of Antivenom to Neutralize the Destructive (Non-Clotting) Fibrinogenolytic Activity of
Grashof D; Zdenek CN; Dobson JS; Youngman NJ; Coimbra F; Benard-Valle M; Alagon A; Fry BG
Toxins (Basel); 2020 Jan; 12(2):. PubMed ID: 32019058
[TBL] [Abstract][Full Text] [Related]
35. Brown spider (Loxosceles genus) venom toxins: Evaluation of biological conservation by immune cross-reactivity.
Buch DR; Souza FN; Meissner GO; Morgon AM; Gremski LH; Ferrer VP; Trevisan-Silva D; Matsubara FH; Boia-Ferreira M; Sade YB; Chaves-Moreira D; Gremski W; Veiga SS; Chaim OM; Senff-Ribeiro A
Toxicon; 2015 Dec; 108():154-66. PubMed ID: 26474948
[TBL] [Abstract][Full Text] [Related]
36. Red-back spider (Latrodectus hasselti) antivenom prevents the toxicity of widow spider venoms.
Graudins A; Padula M; Broady K; Nicholson GM
Ann Emerg Med; 2001 Feb; 37(2):154-60. PubMed ID: 11174232
[TBL] [Abstract][Full Text] [Related]
37. Identification and neutralization of biological activities in the venoms of Loxosceles spiders.
Barbaro KC; Ferreira ML; Cardoso DF; Eickstedt VR; Mota I
Braz J Med Biol Res; 1996 Nov; 29(11):1491-7. PubMed ID: 9196551
[TBL] [Abstract][Full Text] [Related]
38. Generation and molecular characterization of a monoclonal antibody reactive with conserved epitope in sphingomyelinases D from Loxosceles spider venoms.
Dias-Lopes C; Felicori L; Rubrecht L; Cobo S; Molina L; Nguyen C; Galéa P; Granier C; Molina F; Chávez-Olortegui C
Vaccine; 2014 Apr; 32(18):2086-92. PubMed ID: 24565754
[TBL] [Abstract][Full Text] [Related]
39. Determination of sphingomyelinase-D activity of Loxosceles venoms in sphingomyelin/cholesterol liposomes containing horseradish peroxidase.
Gomes MT; Guimarães G; Frézard F; Kalapothakis E; Minozzo JC; Chaim OM; Veiga SS; Oliveira SC; Chávez-Olórtegui C
Toxicon; 2011 Mar; 57(4):574-9. PubMed ID: 21236288
[TBL] [Abstract][Full Text] [Related]
40. Clinical Effects of the Immunization Protocol Using
Miranda ALS; Antunes BC; Minozzo JC; Lima SA; Botelho AFM; Campos MTG; Chávez-Olórtegui CD; Soto-Blanco B
Toxins (Basel); 2022 May; 14(5):. PubMed ID: 35622586
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
